Created: November 22, 2020 07:46 AM
The U.S. Food and Drug Administration has given the green light for emergency authorization for a coronavirus antibody treatment.
The therapy was developed by Regeneron, which has a facility in Rensselaer.
This cocktail is the same one given to President Trump when he contracted COVID-19 in October.
Regeneron submitted an emergency use application after pre-clinical studies showed the therapy reduced the amount of the virus and associated damage in the lungs of non-human primates.
Copyright 2020 - WNYT-TV, LLC A Hubbard Broadcasting Company